540726 — Trident Texofab Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapNeutral

Annual balance sheet for Trident Texofab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.818	0.344	0.388	0.616	1.56
Net Total Accounts Receivable
Net Total Receivables	282	304	309	339	367
Total Inventory
Total Other Current Assets
Total Current Assets	399	400	400	467	521
Net Property, Plant And Equipment	128	231	253	233	217
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	557	678	710	773	819
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	293	303	302	372	423
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	441	558	580	621	656
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	116	120	130	152	163
Total Liabilities & Shareholders' Equity	557	678	710	773	819
Total Common Shares Outstanding
Total Preferred Shares Outstanding